These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23110737)

  • 21. [Detection of soluble fibrin monomer complexes and of platelet factor 4 in the plasma of patients with diabetes mellitus].
    Smolenskij VS; Bokarev IN; Velikov VK; Savina TS; Frolova AI
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):879-84. PubMed ID: 94882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Stability of selected enzymes, proteins and test components of coagulation in low-temperature preservation].
    Banik N; Adam N; Irrgang B; Klengel H; Seifert A; Töpfer G; Zawta B
    Z Med Lab Diagn; 1988; 29(2):119-25. PubMed ID: 3369225
    [No Abstract]   [Full Text] [Related]  

  • 23. Half-life of platelet factor 4 (PF-4) in plasma and platelets from macaca mulatta.
    Gjesdal K; Pepper DS
    Thromb Haemost; 1977 Feb; 37(1):73-80. PubMed ID: 402708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Plasma platelet factor 4 levels in diabetics with various vascular complications: measurement by radiommunoassay (author's transl)].
    Tsukada T; Tsutsui K; Ito T
    Rinsho Ketsueki; 1980 Mar; 21(3):302-7. PubMed ID: 7411869
    [No Abstract]   [Full Text] [Related]  

  • 25. Facilitating blood component preparation: the impact of overnight room temperature storage.
    McLaughlin LS; Moroff G; Benjamin RJ
    Transfusion; 2010 Feb; 50(2):278-80. PubMed ID: 20088837
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of long-term plasmapheresis on blood composition. II. Changes in the concentration of coagulation factors, inhibitors, thrombocytes and its effect on routine tests of coagulation].
    Grgicević D
    Bilt Hematol Transfuz; 1981; 9(1-3):89-100. PubMed ID: 7349762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma beta-thromboglobulins and platelet factor 4 during the normal menstrual cycle.
    Motomiya T; Yamazaki H
    Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):193-5. PubMed ID: 6171983
    [No Abstract]   [Full Text] [Related]  

  • 28. A comparison of centrifugal and membrane-based apheresis formats.
    Gurland HJ; Lysaght MJ; Samtleben W; Schmidt B
    Int J Artif Organs; 1984 Jan; 7(1):35-8. PubMed ID: 6698631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet activation in response to phlebotomy. An experimental study of healthy blood donors.
    Eriksson KA; Sigvaldason A; Lindholm A; Safai-Kutti S; Kutti J
    Acta Med Scand; 1982; 212(3):121-3. PubMed ID: 6183925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C.
    Bihm DJ; Ettinger A; Buytaert-Hoefen KA; Hendrix BK; Maldonado-Codina G; Rock G; Giclas PC; Goodrich RP
    Vox Sang; 2010 Feb; 98(2):108-15. PubMed ID: 19719460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
    Ali SF
    Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of the therapeutic effectiveness of membrane and centrifugation plasmapheresis].
    Opatrný K; Pittrová H; Opatrný K; Kováríková P; Cerhová M; Rusnáková H
    Vnitr Lek; 1990 Oct; 36(10):978-84. PubMed ID: 2256259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between plasma levels of the factor VIII complex and platelet release products (beta-thromboglobulin and platelet factor 4) in children with the hemolytic-uremic syndrome.
    Appiani AC; Edefonti A; Bettinelli A; Cossu MM; Paracchini ML; Rossi E
    Clin Nephrol; 1982 Apr; 17(4):195-9. PubMed ID: 6176380
    [No Abstract]   [Full Text] [Related]  

  • 34. [Plasma beta-thromboglobulin level in thromboembolic diseases: a marker of in-vivo platelet release reaction].
    Modiano A
    G Clin Med; 1980 Sep; 61(9):672-8. PubMed ID: 6162700
    [No Abstract]   [Full Text] [Related]  

  • 35. Solvent-detergent filtered (S/D-F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system.
    El-Ekiaby M; Sayed MA; Caron C; Burnouf S; El-Sharkawy N; Goubran H; Radosevich M; Goudemand J; Blum D; de Melo L; Soulié V; Adam J; Burnouf T
    Transfus Med; 2010 Feb; 20(1):48-61. PubMed ID: 19778318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet activation and allergic asthma.
    Gresele P; Todisco T; Merante F; Nenci GG
    N Engl J Med; 1982 Mar; 306(9):549. PubMed ID: 6173752
    [No Abstract]   [Full Text] [Related]  

  • 37. [Platelet factor 4].
    Hoshiyama M; Shibata A
    Nihon Rinsho; 1979 Jun; Suppl():2208-9. PubMed ID: 491112
    [No Abstract]   [Full Text] [Related]  

  • 38. Platelet activation in antigen-induced bronchoconstriction.
    Knauer KA; Fish JE; Adkinson NF; Lichtenstein LM; Peters SP; Newball HH
    N Engl J Med; 1981 Oct; 305(15):892-3. PubMed ID: 7278891
    [No Abstract]   [Full Text] [Related]  

  • 39. [Plasma levels of beta-thromboglobulin and platelet factor 4 in clinical conditions (author's transl)].
    Motomiya T; Yahara Y; Onozawa Y; Watanabe C; Tomura S; Sano T; Yamazaki H
    Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):864-70. PubMed ID: 6165212
    [No Abstract]   [Full Text] [Related]  

  • 40. Possible therapeutic application of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
    Tojo K; Sakai S; Miyahara T
    Nihon Jinzo Gakkai Shi; 1988 Sep; 30(9):1153-60. PubMed ID: 3216557
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.